A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 601–700 of 1,000
Tratamento da depressão bipolar
Lafer, B., & Soares, M. B. D. M. (2005) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832005000700008 · Cited by 7
Soutullo, C. A., Díez‐Suárez, A., & Quintana, A. F. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.357 · Cited by 7
Bipolar Disorder Clinical Synthesis: Where Does the Evidence Lead?
Sachs, G. S. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.1.3 · Cited by 7
Self-citationAdvancing the pharmacological treatment of bipolar depression
Frangou, S. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.1.28 · Cited by 9
(1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100720 · Cited by 7
Arnone, D., Östlundh, L., Mosa, M., MacDonald, B., Oldershaw, J., Qassem, T., & Young, A. H. (2025) · Pharmaceuticals · doi:10.3390/ph18101590 · Cited by 7
Cheniaux, E. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000100015 · Cited by 7
Friedman, E. S., Calabrese, J. R., Ketter, T. A., Leon, A. C., Thase, M. E., Bowden, C. L., Sylvia, L. G., Ostracher, M. J., Severe, J. B., Iosifescu, D. V., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.052 · Cited by 6
Self-citationToxic Epidermal Necrolysis Due to Lamotrigine Monotherapy for Bipolar Disorder
Tseng, H., & Chang, C. (2009) · Tzu Chi Medical Journal · doi:10.1016/s1016-3190(09)60031-8 · Cited by 6
Possible Lamotrigine-Induced Mania in a Child With Autism Spectrum Disorder and Epilepsy
Coşkun, M., Bozkurt, H., & Zoroglu, S. S. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b6017f · Cited by 6
Management of Bipolar Depression
Chang, J. S., & Ha, K. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85390 · Cited by 8
Efficacy and Safety of Lamotrigine for Adults with Bipolar Disorder in a Private Practice Setting
Ginsberg, L. (2006) · CNS Spectrums · doi:10.1017/s1092852900014504 · Cited by 5
Möller, H. ‐. (2014) · Springer eBooks · doi:10.1007/978-3-319-04627-3_2 · Cited by 7
Role of mood stabilizers in bipolar disorder
Bhagwagar, Z., & Goodwin, G. M. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.2.239 · Cited by 6
Combined Medication and Dialectical Behavior Therapy for Borderline Personality Disorder
Schulz, S. C., & Rafferty, M. P. (2008) · Social Work in Mental Health · doi:10.1300/j200v06n01_11 · Cited by 6
Carson, V. B., & Yambor, S. L. (2012) · Home Healthcare Now · doi:10.1097/nhh.0b013e318252c52b · Cited by 8
Spanemberg, L., Massuda, R., Lovato, L. M., Paim, L. L., Vares, E. A., da Rocha, N. S., & Ceresér, K. M. M. (2011) · Psychiatric Quarterly · doi:10.1007/s11126-011-9191-1 · Cited by 7
Lamotrigine treatment of a patient affected by epilepsy and anxiety disorder.
Šepić-Grahovac, D., Grahovac, T., Baršić, A. R., Ružić, K., & Dadić-Hero, E. (2011) · PubMed · Cited by 6
Psychotropic-Induced Weight Gain: Liability, Mechanisms and Treatment Approaches
McIntyre, R. S., Konarski, J. Z., & Keck, P. E. (2006) · CRC Press eBooks · doi:10.3109/9780849374517.014 · Cited by 6
Pharmacological management of bipolar depression
Haddad, P. M., & Dursun, S. M. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.2e006.x · Cited by 6
On the Anticonvulsant Effect of Acetone and the Ketogenic Diet
Likhodii, S. S., & Burnham, W. M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.235021.x · Cited by 6
Mohr, W. K. (2001) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-20010301-11 · Cited by 6
The Impact of Mood Stabilizers on Suicide in Bipolar Disorder: A Comparative Analysis
Goodwin, F. K., & Ghaemi, S. N. (2000) · CNS Spectrums · doi:10.1017/s1092852900023245 · Cited by 7
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies
Fellendorf, F. T., Caboni, E., Paribello, P., Pinna, M., d’Aloja, E., Carucci, S., Pinna, F., Reininghaus, E. Z., Carpiniello, B., & Manchia, M. (2023) · Pharmaceuticals · doi:10.3390/ph16020182 · Cited by 5
A Pilot Study of High-Frequency Transcranial Magnetic Stimulation for Bipolar Depression
Aaronson, S. T., Goldwaser, E. L., Croarkin, P. E., Geske, J. R., LeMahieu, A., Sklar, J., & Kung, S. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m15056 · Cited by 5
Fredskild, M. U., Bruun, C. F., Vinberg, M., Faurholt‐Jepsen, M., Kessing, L. V., & Munkholm, K. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.125 · Cited by 7
Drug Class Review: Antiepileptic Drugs for Indications Other Than Epilepsy
McDonagh, M. S., Peterson, K., Lee, N., & Thakurta, S. (2008) · Cited by 7
Gao, K., Kemp, D. E., Wu, R., & Calabrese, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch105 · Cited by 9
Self-citationZhang, L., Zhang, H., Lv, L., Tan, Q., Xu, X., Hu, J. S., Zi, L., Cooper, J. A., Phansalkar, A., & Wang, G. (2022) · International Journal of Bipolar Disorders · doi:10.1186/s40345-022-00266-4 · Cited by 5
Diagnosis and Treatment of Mixed States
Swann, A. C. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch19 · Cited by 5
Biological aspects of rapid-cycling and mixed states
Grunze, H., & Walden, J. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.015 · Cited by 5
Akingbala, F., Dhanani, N., & Brown, E. S. (2006) · Journal of Dual Diagnosis · doi:10.1300/j374v02n03_07 · Cited by 5
Neurobiologia do transtorno de humor bipolar e tomada de decisão na abordagem psicofarmacológica
Machado‐Vieira, R., Schwartzhaupt, A. W., Frey, B. N., Lenadro, J. J., Ceresér, K. M. M., da Silveira, L. N., Zanatta, L. M., Garcia, P. F., Pollet, P., Braga, V. F., et al. (2003) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082003000400010 · Cited by 15
Treatment-Resistant Bipolar Disorder
Gitlin, M. J. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.1.49 · Cited by 5
Bipolar affective disorder: gender differences in the course and treatment
Tyuvina, N. A., Stolyarova, A. E., & Смирнова, В. Н. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119121162 · Cited by 5
The effectiveness of lamotrigine for persistent depressive disorder: A case report
Matsuzaka, Y., Urashima, K., Sakai, S., Morimoto, Y., Kanegae, S., Kinoshita, H., Imamura, A., & Ozawa, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12228 · Cited by 5
Yoshida, M., Hasegawa, S., Taniguchi, M., Mouri, A., Suzuki, C., Yoshimi, A., Mamiya, T., Ozaki, N., & Noda, Y. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109208 · Cited by 8
Chapter 49. Treatment of Bipolar Disorder
Strakowski, S. M., & Keck, P. E. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as49 · Cited by 5
Treatment of Bipolar Depression
Post, R. M., Baldassano, C. F., Perlis, R. H., & Ginsberg, D. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_5 · Cited by 5
Nolen, W. A., & Kupka, R. (2000) · Acta Neuropsychiatrica · doi:10.1017/s0924270800035572 · Cited by 5
14.8 MOOD DISORDERS: TREATMENT OF BIPOLAR DISORDERS
Post, R. M. (2004) · Cited by 5
Polypharmazie in der Behandlung depressiver Störungen
Schmauß, M., & Messer, T. (2009) · Springer eBooks · doi:10.1007/978-3-211-79826-3_1 · Cited by 5
Emerging drugs for bipolar disorder
Mitchell, P. B., & Malhi, G. S. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.4.621 · Cited by 5
The challenges of pharmacotherapy of bipolar depression
Thase, M. E., & Sachs, G. S. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00045-2 · Cited by 5
Self-citationThe Emerging Role of Olanzapine in Bipolar Disorders
Ketter, T. A., Wang, P. W., Janenawasin, S., Becker, O. V., & Wang, A. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20021201-10 · Cited by 5
The “Softer” End of the Bipolar Spectrum
Pies, R. W. (2002) · Journal of Psychiatric Practice · doi:10.1097/00131746-200207000-00002 · Cited by 5
Calabrese, J. R. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00022-x · Cited by 5
Self-citation(2005) · CRC Press eBooks · doi:10.1201/b14455-5 · Cited by 5
Young, A. H., Geddes, J. R., Macritchie, K., Rao, S., & Vasudev, A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004694 · Cited by 5
Modafinil: Mischaracterization
Kruszewski, S. P., & Klotz, S. G. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624b · Cited by 5
Challenges in the development of treatment guidelines for bipolar disorder
Fountoulakis, K. Ν., Fountoulakis, N. K., & Antoniadis, D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1564004 · Cited by 5
Emerging neurobiological targets in psychiatric treatment
Zoysa, A. I. D., Govinnage, J., Giorlando, F., Dodd, S., Narayanaswamy, J., & Berk, M. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112767 · Cited by 4
Diagnosis and Treatment of Mania in the Psychiatric Emergency Service
Allen, M. H., & Currier, G. W. (2000) · Psychiatric Annals · doi:10.3928/0048-5713-20000401-10 · Cited by 4
Outcome measures in treatment trials in bipolar disorder
Nolen, W. A. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.4.s1.26.x · Cited by 4
What psychotherapists should know about pharmacotherapies for bipolar disorder
Goldberg, J. F. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20362 · Cited by 4
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Bogen, D. L., Altemus, M. M., Pearlstein, T. B., Svikis, D. S., Misra, D. P., & Miller, E. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00055-x · Cited by 5
Goodman, F., Glassman, P. A., Maglione, M., Booth, M. S., Rhodes, S. L., Ma, Q., Rolón, C., & Shekelle, P. (2006) · Cited by 5
Tratamento farmacológico do transtorno bipolar: as evidências de ensaios clínicos randomizados
Kapczinski, F. P., Gazalle, F. K., Frey, B. N., Kauer‐Sant’Anna, M., & Tramontina, J. (2005) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832005000700006 · Cited by 7
Mood disorders in neurologic illness
Schneck, C. D., & Buzan, R. D. (2000) · Current Treatment Options in Neurology · doi:10.1007/s11940-000-0016-z · Cited by 4
Lamotrigine as an adjuvant treatment for acute bipolar depression: A Brazilian naturalistic study.
Silveira, L. A. S., Novis, F. D., da Silva, R. O., Nunes, A. L. S., Coscarelli, P. G., & Cheniaux, E. (2013) · Psychology & Neuroscience · doi:10.3922/j.psns.2013.1.16 · Cited by 4
Chrościńska–Krawczyk, M., Wałek, M., Tylus, B., & Czuczwar, S. J. (2014) · Journal of Epileptology · doi:10.1515/joepi-2015-0013 · Cited by 4
Fuller, M. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_34 · Cited by 4
Drug treatments for bipolar disorder: 1 - Acute manic or depressive
(2005) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2005.43428 · Cited by 4
Antiepileptic Drugs in the Treatment of Anxiety Disorders: Role in Therapy
Ameringen, M. V., Mancini, C., Patterson, B. A., & Truong, C. (2008) · Medical psychiatry · doi:10.3109/9780849382666.012 · Cited by 4
Woo, Y. S., Bahk, W., Pae, C., Jeong, J., Koo, B., Jon, D., Lee, J. G., & Kim, M.-D. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12095 · Cited by 4
Joseph, C. J., & Mok, Y. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.011 · Cited by 4
An Impaired Physician With Complex Comorbidity
Petersen-Crair, P., Marangell, L. B., Flack, J. N., Harper, R. G., Soety, E. M., & Gabbard, G. O. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.850 · Cited by 4
Psychiatric Uses of Newer Anticonvulsants
Berigan, T. R. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0207 · Cited by 4
The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action
Amann, B. L., & Grunze, H. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.1.107 · Cited by 4
A lamotrigina pode induzir virada maníaca?
Cheniaux, E., Dias, A., Lessa, J. L. M., & Versiani, M. (2005) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082005000200011 · Cited by 4
Treatment of Bipolar Depression
Dunn, R. T., & Post, R. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-792-5_4 · Cited by 4
La dépression bipolaire. Aspects cliniques et thérapeutiques
Bourgeois, M.-L. (2001) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/s0003-4487(01)00040-3 · Cited by 4
A Review of Vagus Nerve Stimulation for Treatment-Resistant Depression
Marangell, L. B., Rush, A. J., George, M. S., Georges, D., & Sackeïm, H. A. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0209 · Cited by 4
Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders
Lieberman, D. Z., & Goodwin, F. K. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0011-2 · Cited by 7
The inhibition of phosphodiesterase type 5 as a novel target for antidepressant action
Liebenberg, N. (2009) · Cited by 5
Polypharmacy of Bipolar Disorder
Ko, J. Y. (2002) · CRC Press eBooks · doi:10.1201/b15278-3 · Cited by 8
Pharmacological treatment of bipolar depression
Young, A. H., & Nemeroff, C. B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.004 · Cited by 3
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_16 · Cited by 3
Advances in Design and Development of Sodium Channel Blockers
Zuliani, V., Amori, L., & Rivara, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6_4 · Cited by 4
Okunji, P. O., Ezebuihe, I., & Okunji, C. (2020) · Family Medicine and Primary Care Open Access · doi:10.29011/2688-7460.100041 · Cited by 3
Pary, R., Matuschka, P. R., Lewis, S., & Lippmann, S. (2006) · PubMed Central · Cited by 4
do Nascimento, G. N. L., Pereira, K. C. D. F., Nishijo, H., & Aversi‐Ferreira, T. A. (2011) · Acta Scientiarum Health Sciences · doi:10.4025/actascihealthsci.v33i2.8244 · Cited by 3
Bipolar II or Unipolar Depression: Pharmacologic Considerations
Antai-Otong, D. (2004) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2004.tb00008.x · Cited by 3
Advanced Pediatric Psychopharmacology
Vito, J., Jummani, R. R., & Coffey, B. J. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.498 · Cited by 3
Masand, P. M., & Mago, R. (2005) · Evidence-Based Mental Health · doi:10.1136/ebmh.8.2.35 · Cited by 3
Hussain, A., Shah, M. S., Roub, F. E., Dar, M. A., Wani, Z. A., Jan, M. M., Wani, R. A., & Bhat, T. A. (2015) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.162916 · Cited by 3
Treatment of Refractory Depression
Gitlin, M. J. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch15 · Cited by 3
Biological Treatments of Mood Disorders
Ebmeier, K. P., Berge, A., Semple, D. M., Shah, P. J., & Steele, J. D. (2004) · Wiley eBooks · doi:10.1002/9780470696385.ch7 · Cited by 3
Dossett, E. C., Land, A. J., Gitlin, M. J., & Frye, M. A. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624e · Cited by 3
Bipolar disorders: new approaches to therapy
Watson, S., & Young, A. H. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.4.601 · Cited by 5
Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling
Datta, V., & Cleare, A. J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.10 · Cited by 3
Bipolar Disorder in Later Life
Forester, B. P., & Jordan, B. L. (2008) · Medical psychiatry · doi:10.3109/9781420053302.004 · Cited by 3
Platelet Glutamate Receptors as a Window into Psychiatric Disorders
Berk, M. (2007) · Springer eBooks · doi:10.1007/0-306-48644-x_15 · Cited by 3
Wisner, K. L., Sit, D. K. Y., Reynolds, S. K., Altemus, M. M., Bogen, D. L., Sunder, K. R., Misra, D. P., & Perel, J. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06930-7.50052-9 · Cited by 3
Pharmacotherapy for Bipolar Depression: A Review of the Evidence
Aarre, T. F., & Dahl, A. A. (2008) · Current Psychiatry Reviews · doi:10.2174/157340008785829913 · Cited by 3
Stoner, S. C., Lea, J. W., Wolf, A. L., & Berges, A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g320 · Cited by 3
Khairkar, P. H., Khivsara, A., Kamble, A., Modi, R., Bamal, I., & Doshi, C. (2025) · Archives of Biological Psychiatry · doi:10.25259/abp_16_2025 · Cited by 2
Carpenter, L. L., Wyche, M. C., Friehs, G. M., & O’Reardon, J. P. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374248-3.00055-0 · Cited by 2
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.017 · Cited by 2
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.